Laura E. Avena is a Senior Scientist at Moderna since June 2021, where responsibilities include leading preclinical research strategies for various vaccine programs and managing operational aspects of annual COVID-19 vaccine updates. Previously, Laura served as a Scientist focused on respiratory vaccine development and assay optimization. Prior experience includes a Graduate Student role at Boston University School of Medicine, where Laura established a regulated vaccine preclinical program and led training for GLP animal studies, as well as research at The University of Texas Health Science Center investigating Filoviruses. Laura's earlier roles at Texas Biomedical Research Institute involved assay development and regulatory compliance. Laura holds a PhD in Cellular Genetic and Molecular Medicine and a BS in Biology.
This person is not in any teams
This person is not in any offices